A Pharmacokinetic Comparison Study of SYHX2011 and Abraxane® in Patients With Advanced Breast Cancer
This is a multi-center, open-label, pharmacokinetic comparison study of SYHX2011 and Abraxane® in patients with advanced breast cancers after single IV infusion.
Advanced Breast Cancer
DRUG: SYHX2011 and Abraxane®
Cmax, Maximum plasma concentration, From time zero up to 72 hours post-dose|AUC0-t, Area under the plasma concentration time curve from time zero to the last measurable concentration, From time zero up to 72 hours post-dose|AUC0-∞, Area under the plasma concentration-time curve from time zero to infinity, From time zero up to 72 hours post-dose
This is a multi-center, open-label, pharmacokinetic comparison study of SYHX2011 and Abraxane® in patients with advanced breast cancers after single IV infusion.